These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8903960)

  • 1. In vitro receptor binding characteristics of the new dopamine D2 antagonist [125I]NCQ-298: methodological considerations of high affinity binding.
    Jerning E; Malmberg A; Mohell N
    J Recept Signal Transduct Res; 1995; 15(1-4):503-15. PubMed ID: 8903960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.
    Malmberg A; Jerning E; Mohell N
    Eur J Pharmacol; 1996 May; 303(1-2):123-8. PubMed ID: 8804920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonist binding characteristics of the Ser311-->Cys variant of human dopamine D2 receptor in vivo and in vitro.
    Pohjalainen T; Cravchik A; Gejman PV; Rinne J; Någren K; Syvälahti E; Hietala J
    Biochem Biophys Res Commun; 1997 Mar; 232(1):143-6. PubMed ID: 9125119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
    Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
    Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
    Schetz JA; Chu A; Sibley DR
    J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
    Patel S; Patel S; Marwood R; Emms F; Marston D; Leeson PD; Curtis NR; Kulagowski JJ; Freedman SB
    Mol Pharmacol; 1996 Dec; 50(6):1658-64. PubMed ID: 8967990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
    Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
    Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
    Dewar KM; Montreuil B; Grondin L; Reader TA
    J Pharmacol Exp Ther; 1989 Aug; 250(2):696-706. PubMed ID: 2527300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses of [123I]-, [125I]- and unlabelled (S)-3-iodo-5,6-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]salicylamide (NCQ 298), selective ligands for the study of dopamine D-2 receptors.
    Högberg T; Ström P; Hall H; Köhler C; Halldin C; Farde L
    Acta Pharm Nord; 1990; 2(1):53-60. PubMed ID: 1971177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical regulation of dopamine receptors in transfected 293 cells.
    Filtz TM; Artymyshyn RP; Guan W; Molinoff PB
    Mol Pharmacol; 1993 Aug; 44(2):371-9. PubMed ID: 8102783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
    Sautel F; Griffon N; Sokoloff P; Schwartz JC; Launay C; Simon P; Costentin J; Schoenfelder A; Garrido F; Mann A
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1239-46. PubMed ID: 8531087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors.
    Hall H; Högberg T; Halldin C; Köhler C; Ström P; Ross SB; Larsson SA; Farde L
    Psychopharmacology (Berl); 1991; 103(1):6-18. PubMed ID: 1672460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.
    Malmberg A; Jackson DM; Eriksson A; Mohell N
    Mol Pharmacol; 1993 May; 43(5):749-54. PubMed ID: 8099194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiinjection approach for D2 receptor binding quantification in living rats using [11C]raclopride and the beta-microprobe: crossvalidation with in vitro binding data.
    Mauger G; Saba W; Hantraye P; Dolle F; Coulon C; Bramoullé Y; Chalon S; Grégoire MC
    J Cereb Blood Flow Metab; 2005 Nov; 25(11):1517-27. PubMed ID: 15917750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL; Schaus JM; Gehlert DR
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]Pramipexole: a selective radioligand for the high affinity dopamine D2 receptor in bovine striatal membranes.
    Ohnmacht U; Tränkle C; Mohr K; Gmeiner P
    Pharmazie; 1999 Apr; 54(4):294-7. PubMed ID: 10234741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of dopamine D2-receptor selective antagonists.
    Högberg T
    Drug Des Discov; 1993; 9(3-4):333-50. PubMed ID: 8400011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
    Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.